Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial

Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, and the Back to Top element was removed. Overall, this is a minor update with no changes to core content, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-14T23:49:52.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T20:31:18.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new resources related to genetic and rare diseases, specifically focusing on polymyositis and dermatomyositis, while removing previous references to idiopathic inflammatory myopathy and inclusion body myositis.
    Difference
    5%
    Check dated 2025-08-31T12:48:13.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-24T09:23:48.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    1.0%
    Check dated 2025-08-17T05:15:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:59:16.000Z thumbnail image

Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.